The Emerging Role of Biotechnological Drugs in the Treatment of Gout

First Page		Document Content
Rheumatology Non-steroidal anti-inflammatory drugs Inborn errors of purine-pyrimidine metabolism Uric acid Arthritis Gout Anakinra Tophus Rasburicase Medicine Health Chemistry		The Emerging Role of Biotechnological Drugs in the Treatment of Gout Add to Reading List Source URL: www.ncbi.nlm.nih.gov Download Document from Source Website File Size: 566,39 KB Share Document on Facebook

	KICK-OFF MEETING 1st-3rd October 2013 Kennedy Institute Of Rheumatology, Roosevelt Drive, Headington - Oxford, OX3 7FY - UK DocID: 1vpYJ - View Document
	10th Orthopedics & Rheumatology Annual Meeting & Expo Aug 31-Sept 1, 2018 Toronto \| Ontario \| Canada Tentative Program DocID: 1vnha - View Document
	Selected Topics in Clinical Immunology - BiologicsBiomedical Sciences March 1, 2018 S. Adler RIA Department of Rheumatology, Immunology and Allergology DocID: 1v3Pj - View Document
	A N N U A L M E E T I N G 28th-29th SeptemberKennedy Institute of Rheumatology - Oxford - UK LIST OF PARTICIPANTS DocID: 1uKoJ - View Document
	Reprinted from: The Journal of the Canadian Rheumatology Association / Volume 28, Number 1, Spring 2018, ppJOINT COMMUNIQUÉ Models of Care: The International Perspective DocID: 1ujSW - View Document